Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs WYETH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GLENMARK PHARMA WYETH GLENMARK PHARMA/
WYETH
 
P/E (TTM) x -31.4 27.7 - View Chart
P/BV x 2.9 11.3 25.4% View Chart
Dividend Yield % 0.3 10.9 2.4%  

Financials

 GLENMARK PHARMA   WYETH
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
WYETH
Mar-14
GLENMARK PHARMA/
WYETH
5-Yr Chart
Click to enlarge
High Rs4871,065 45.7%   
Low Rs349553 63.1%   
Sales per share (Unadj.) Rs460.4289.5 159.0%  
Earnings per share (Unadj.) Rs13.438.7 34.6%  
Cash flow per share (Unadj.) Rs35.039.9 87.8%  
Dividends per share (Unadj.) Rs2.50145.00 1.7%  
Avg Dividend yield %0.617.9 3.3%  
Book value per share (Unadj.) Rs335.1118.5 282.7%  
Shares outstanding (eoy) m282.1722.72 1,241.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.8 32.5%   
Avg P/E ratio x31.320.9 149.5%  
P/CF ratio (eoy) x11.920.3 58.8%  
Price / Book Value ratio x1.26.8 18.3%  
Dividend payout %18.7374.7 5.0%   
Avg Mkt Cap Rs m117,95318,381 641.7%   
No. of employees `000NANA-   
Total wages/salary Rs m27,810359 7,757.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m129,9016,577 1,975.0%  
Other income Rs m3,168347 911.9%   
Total revenues Rs m133,0696,925 1,921.7%   
Gross profit Rs m15,1251,023 1,478.2%  
Depreciation Rs m6,11327 22,325.3%   
Interest Rs m3,4964 79,631.7%   
Profit before tax Rs m8,6851,339 648.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,911460 1,068.4%   
Profit after tax Rs m3,774879 429.3%  
Gross profit margin %11.615.6 74.8%  
Effective tax rate %56.534.3 164.7%   
Net profit margin %2.913.4 21.7%  
BALANCE SHEET DATA
Current assets Rs m98,7373,964 2,490.8%   
Current liabilities Rs m50,4552,081 2,424.4%   
Net working cap to sales %37.228.6 129.8%  
Current ratio x2.01.9 102.7%  
Inventory Days Days735 19.1%  
Debtors Days Days115278 41.5%  
Net fixed assets Rs m76,920878 8,762.1%   
Share capital Rs m282227 124.2%   
"Free" reserves Rs m94,2812,466 3,823.7%   
Net worth Rs m94,5632,693 3,511.6%   
Long term debt Rs m38,52125 153,962.4%   
Total assets Rs m175,6584,842 3,627.9%  
Interest coverage x3.5306.0 1.1%   
Debt to equity ratio x0.40 4,384.4%  
Sales to assets ratio x0.71.4 54.4%   
Return on assets %4.118.2 22.7%  
Return on equity %4.032.6 12.2%  
Return on capital %9.249.4 18.5%  
Exports to sales %00.1 0.0%   
Imports to sales %034.7 0.0%   
Exports (fob) Rs mNA8 0.0%   
Imports (cif) Rs mNA2,281 0.0%   
Fx inflow Rs m46,4648 610,560.6%   
Fx outflow Rs m12,7122,298 553.1%   
Net fx Rs m33,751-2,291 -1,473.4%   
CASH FLOW
From Operations Rs m6,2541,188 526.3%  
From Investments Rs m-5,285287 -1,842.3%  
From Financial Activity Rs m-775-4,296 18.0%  
Net Cashflow Rs m325-2,821 -11.5%  

Share Holding

Indian Promoters % 46.7 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 34.7 18.4 188.6%  
FIIs % 23.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 53.4 48.9 109.1%  
Shareholders   209,931 25,706 816.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GLENMARK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Glenmark Pharma vs WYETH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Glenmark Pharma vs WYETH Share Price Performance

Period Glenmark Pharma WYETH S&P BSE HEALTHCARE
1-Day -0.57% -2.27% 1.18%
1-Month 5.16% 18.58% -0.75%
1-Year 112.94% 69.59% 61.82%
3-Year CAGR 27.51% 15.36% 18.16%
5-Year CAGR 8.05% 8.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Glenmark Pharma share price and the WYETH share price.

Moving on to shareholding structures...

The promoters of Glenmark Pharma hold a 46.7% stake in the company. In case of WYETH the stake stands at 51.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Glenmark Pharma and the shareholding pattern of WYETH.

Finally, a word on dividends...

In the most recent financial year, Glenmark Pharma paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 18.7%.

WYETH paid Rs 145.0, and its dividend payout ratio stood at 374.7%.

You may visit here to review the dividend history of Glenmark Pharma, and the dividend history of WYETH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.